Literature DB >> 16616811

The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells.

Laurent Bartholin1, Lisa L Wessner, John M Chirgwin, Theresa A Guise.   

Abstract

Cyr61 is a multifunctional protein that can stimulate angiogenesis and tumor growth. Its expression by many cancers and breast cancers increases with tumor grade. Cyr61 is closely related to connective tissue growth factor, CTGF. Both proteins regulate skeletal development, suggesting that they could contribute to breast cancer metastases to bone, a process regulated by TGFbeta. We show that Cyr61 transcription is activated by TGFbeta and that the human Cyr61 promoter contains consensus sequences that bind Smad proteins. TGFbeta in the tumor microenvironment may stimulate cancer metastases to sites such as bone by increasing Cyr61 expression and secretion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616811     DOI: 10.1016/j.canlet.2006.02.019

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  YAP and TAZ Mediate Osteocyte Perilacunar/Canalicular Remodeling.

Authors:  Christopher D Kegelman; Jennifer C Coulombe; Kelsey M Jordan; Daniel J Horan; Ling Qin; Alexander G Robling; Virginia L Ferguson; Teresita M Bellido; Joel D Boerckel
Journal:  J Bone Miner Res       Date:  2019-10-14       Impact factor: 6.741

2.  Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma.

Authors:  Afak Rasheed Salman Zaidi; Sadie Dresman; Charlotte Burt; Simon Rule; Lynn McCallum
Journal:  J Cell Commun Signal       Date:  2018-11-21       Impact factor: 5.782

3.  TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.

Authors:  Rachel A Hesler; Jennifer J Huang; Mark D Starr; Victoria M Treboschi; Alyssa G Bernanke; Andrew B Nixon; Shannon J McCall; Rebekah R White; Gerard C Blobe
Journal:  Carcinogenesis       Date:  2016-11-01       Impact factor: 4.944

4.  Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis.

Authors:  Zhiyuan Zhang; Hao Wang; Sadakatsu Ikeda; Frederic Fahey; Diane Bielenberg; Patrick Smits; Peter V Hauschka
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

5.  Genomic signatures of breast cancer metastasis.

Authors:  V Urquidi; S Goodison
Journal:  Cytogenet Genome Res       Date:  2007       Impact factor: 1.636

6.  Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL-mutant renal carcinoma cells.

Authors:  Mastan R Chintalapudi; Margaret Markiewicz; Nurgun Kose; Vincent Dammai; Kristen J Champion; Rana S Hoda; Maria Trojanowska; Tien Hsu
Journal:  Carcinogenesis       Date:  2008-01-22       Impact factor: 4.944

7.  The matricellular protein CCN1 enhances TGF-β1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury.

Authors:  Ashish R Kurundkar; Deepali Kurundkar; Sunad Rangarajan; Morgan L Locy; Yong Zhou; Rui-Ming Liu; Jaroslaw Zmijewski; Victor J Thannickal
Journal:  FASEB J       Date:  2016-02-16       Impact factor: 5.191

8.  Singular value decomposition-based regression identifies activation of endogenous signaling pathways in vivo.

Authors:  Zhandong Liu; Min Wang; James V Alvarez; Megan E Bonney; Chien-chung Chen; Celina D'Cruz; Tien-chi Pan; Mahlet G Tadesse; Lewis A Chodosh
Journal:  Genome Biol       Date:  2008-12-18       Impact factor: 13.583

9.  Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.

Authors:  Lauren K Dunn; Khalid S Mohammad; Pierrick G J Fournier; C Ryan McKenna; Holly W Davis; Maria Niewolna; Xiang Hong Peng; John M Chirgwin; Theresa A Guise
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

10.  Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma.

Authors:  Zhu-Qing Zhou; Wei-Hua Cao; Jian-Jun Xie; Jing Lin; Zhong-Ying Shen; Qing-Ying Zhang; Jin-Hui Shen; Li-Yan Xu; En-Min Li
Journal:  BMC Cancer       Date:  2009-08-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.